Citations (29)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Sheng-Min Wang, Changsu Han, Soo-Jung Lee, Tae-Youn Jun, Ashwin A. Patkar, Prakash S. Masand & Chi-Un Pae. (2017) Investigational dopamine antagonists for the treatment of schizophrenia. Expert Opinion on Investigational Drugs 26:6, pages 687-698.
Read now
Read now
Articles from other publishers (28)
Farzaneh Nazari Serenjeh, Narjes Lotfi-Ghadikolaii, Saeed Mohsenipour & Zahra Ghasemzadeh. (2022) Human-Induced Pluripotent Stem Cells are a Unique Approach for Modeling Schizophrenia: Calcium Homeostasis. The Neuroscience Journal of Shefaye Khatam 10:3, pages 98-112.
Crossref
Crossref
Viacheslav Terevnikov & Grigori Joffe. (2022) Mirtazapine in schizophrenia – an undeservedly overlooked option?. International Clinical Psychopharmacology 37:4, pages 131-142.
Crossref
Crossref
Jaime Kulisevsky, Saul Martínez-Horta, Antonia Campolongo, Berta Pascual-Sedano, Juan Marín-Lahoz, Helena Bejr-kasem, Ignacio Aracil-Bolaños, Andrea Horta-Barba, Arnau Puig-Davi & Javier Pagonabarraga. (2022) A Randomized Clinical Trial to Evaluate the Effects of Safinamide on Apathetic Non-demented Patients With Parkinson's Disease. Frontiers in Neurology 13.
Crossref
Crossref
Carolina Muguruza & Luis F. Callado. 2022. Glutamate and Neuropsychiatric Disorders. Glutamate and Neuropsychiatric Disorders
493
521
.
Chung-Chieh Hung, Chieh-Hsin Lin & Hsien-Yuan Lane. (2021) Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment. International Journal of Molecular Sciences 22:18, pages 9718.
Crossref
Crossref
Stjepan Curic, Christina Andreou, Guido Nolte, Saskia Steinmann, Stephanie Thiebes, Nenad Polomac, Moritz Haaf, Jonas Rauh, Gregor Leicht & Christoph Mulert. (2021) Ketamine Alters Functional Gamma and Theta Resting-State Connectivity in Healthy Humans: Implications for Schizophrenia Treatment Targeting the Glutamate System. Frontiers in Psychiatry 12.
Crossref
Crossref
Kah Kheng Goh, Tzu-Hua Wu, Chun-Hsin Chen & Mong-Liang Lu. (2021)
Efficacy of
N
-methyl-
D
-aspartate receptor modulator augmentation in schizophrenia: A meta-analysis of randomised, placebo-controlled trials
. Journal of Psychopharmacology 35:3, pages 236-252.
Crossref
Crossref
Jakob Kaminski, Lea Mascarell-Maricic, Yu Fukuda, Teresa Katthagen, Andreas Heinz & Florian Schlagenhauf. (2021) Glutamate in the Dorsolateral Prefrontal Cortex in Patients With Schizophrenia: A Meta-analysis of 1H-Magnetic Resonance Spectroscopy Studies. Biological Psychiatry 89:3, pages 270-277.
Crossref
Crossref
Shi-Wei Xu, Min Dong, Qinge Zhang, Shu-Yu Yang, Lian-Yu Chen, Kang Sim, Yan-Ling He, Helen FK Chiu, Norman Sartorius, Chay-Hoon Tan, Mian-Yoon Chong, Naotaka Shinfuku, Shih-Ku Lin, Chee H. Ng, Gabor S. Ungvari, Eunice Najoan, Roy Abraham Kallivayalil, Ruzita Jamaluddin, Afzal Javed, Hitoshi Iida, Thiha Swe, Bin Zhang & Yu-Tao Xiang. (2020) Clozapine prescription pattern in patients with schizophrenia in Asia: The REAP survey (2016). Psychiatry Research 287, pages 112271.
Crossref
Crossref
Naista Zhand, David G. Attwood & Philip D. Harvey. (2019) Glutamate modulators for treatment of schizophrenia. Personalized Medicine in Psychiatry 15-16, pages 1-12.
Crossref
Crossref
Josep Maria Haro, Carlo Altamura, Ricardo Corral, Helio Elkis, Jonathan Evans, Marie-Odile Krebs, Mathias Zink, Ashok Malla, José Ignacio Méndez, Corrado Bernasconi, Justine Lalonde & Anna-Lena Nordstroem. (2018) Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study. Psychiatry Research 267, pages 56-62.
Crossref
Crossref
Mitul A. Mehta, Anne Schmechtig, Vasileia Kotoula, Juliet McColm, Kimberley Jackson, Claire Brittain, Sitra Tauscher-Wisniewski, Bruce J. Kinon, Paul D. Morrison, Thomas Pollak, Timothy Mant, Steven C. R. Williams & Adam J. Schwarz. (2018) Group II metabotropic glutamate receptor agonist prodrugs LY2979165 and LY2140023 attenuate the functional imaging response to ketamine in healthy subjects. Psychopharmacology 235:7, pages 1875-1886.
Crossref
Crossref
Eva Drazanova, Jana Ruda-Kucerova, Lucie Kratka, Katerina Horska, Regina Demlova, Zenon StarcukJr.Jr. & Tomas Kasparek. (2018) Poly(I:C) model of schizophrenia in rats induces sex-dependent functional brain changes detected by MRI that are not reversed by aripiprazole treatment. Brain Research Bulletin 137, pages 146-155.
Crossref
Crossref
Zhemeng Wu, Zhigang Yang, Mengjiao Zhang, Xiaohan Bao, Fang Han & Liang Li. (2018) The role of N-methyl-d-aspartate receptors and metabotropic glutamate receptor 5 in the prepulse inhibition paradigms for studying schizophrenia: pharmacology, neurodevelopment, and genetics. Behavioural Pharmacology 29:1, pages 13-27.
Crossref
Crossref
Marco Solmi, Nicola Veronese, Nita Thapa, Silvia Facchini, Brendon Stubbs, Michele Fornaro, André F. Carvalho & Christoph U. Correll. (2017) Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia. CNS Spectrums 22:5, pages 415-426.
Crossref
Crossref
Morgana Moretti, Daiane Bittencourt Fraga & Ana Lúcia S. Rodrigues. (2017) Ascorbic Acid to Manage Psychiatric Disorders. CNS Drugs 31:7, pages 571-583.
Crossref
Crossref
Amir A. Sepehry, Michael Sarai & Ging-Yuek R. Hsiung. (2017) Pharmacological Therapy for Apathy in Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 44:3, pages 267-275.
Crossref
Crossref
Minela Hadzic, Alexander Jack & Petra Wahle. (2017) Ionotropic glutamate receptors: Which ones, when, and where in the mammalian neocortex. Journal of Comparative Neurology 525:4, pages 976-1033.
Crossref
Crossref
Kolja Schiltz, Maria Schöne & Bernhard Bogerts. (2016) Beitrag der Neurowissenschaften zur forensischen PsychiatrieContribution of neurosciences to forensic psychiatry. Forensische Psychiatrie, Psychologie, Kriminologie 10:4, pages 274-283.
Crossref
Crossref
Gary Remington, George Foussias, Gagan Fervaha, Ofer Agid, Hiroyoshi Takeuchi, Jimmy Lee & Margaret Hahn. (2016) Treating Negative Symptoms in Schizophrenia: an Update. Current Treatment Options in Psychiatry 3:2, pages 133-150.
Crossref
Crossref
Savita G. Bhakta, Hsun-Hua Chou, Brinda Rana, Jo A. Talledo, Bryan Balvaneda, Laura Gaddis, Gregory A. Light & Neal R. Swerdlow. (2016) Effects of acute memantine administration on MATRICS Consensus Cognitive Battery performance in psychosis: Testing an experimental medicine strategy. Psychopharmacology 233:12, pages 2399-2410.
Crossref
Crossref
Byung Dae Lee, Je Min Park, Young Min Lee, Eunsoo Moon, Hee Jeong Jeong, Young In Chung & Young Mi Yi. (2016) Heritability and Familiality of Temperament and Character Dimensions in Korean Families with Schizophrenic Linkage Disequilibrium. Clinical Psychopharmacology and Neuroscience 14:2, pages 203-209.
Crossref
Crossref
Annette B. Brühl & Barbara J. Sahakian. (2016) Drugs, games, and devices for enhancing cognition: implications for work and society. Annals of the New York Academy of Sciences 1369:1, pages 195-217.
Crossref
Crossref
Mathias Zink & Susanne Englisch. (2016) Schizophrenia treatment: an obstacle course. The Lancet Psychiatry 3:4, pages 310-312.
Crossref
Crossref
Scott O. LilienfeldMichael T. Treadway. (2016) Clashing Diagnostic Approaches: DSM-ICD Versus RDoC. Annual Review of Clinical Psychology 12:1, pages 435-463.
Crossref
Crossref
Joseph Gonzalez-Heydrich, Michelle Bosquet Enlow, Eugene D’Angelo, Larry J. Seidman, Sarah Gumlak, April Kim, Kristen A. Woodberry, Ashley Rober, Sahil Tembulkar, Kyle O’Donnell, Hesham M. Hamoda, Kara Kimball, Alexander Rotenberg, Lindsay M. Oberman, Alvaro Pascual-Leone, Matcheri S. Keshavan & Frank H. Duffy. (2016) N100 Repetition Suppression Indexes Neuroplastic Defects in Clinical High Risk and Psychotic Youth. Neural Plasticity 2016, pages 1-11.
Crossref
Crossref
Chieh-Hsin Lin, Pei-Pei Lin, Chun-Yuan Lin, Ching-Hua Lin, Chiung-Hsien Huang, Yu-Jhen Huang & Hsien-Yuan Lane. (2016) Decreased mRNA expression for the two subunits of system xc−, SLC3A2 and SLC7A11, in WBC in patients with schizophrenia: Evidence in support of the hypo-glutamatergic hypothesis of schizophrenia. Journal of Psychiatric Research 72, pages 58-63.
Crossref
Crossref
Matteo Cella, Clare Reeder & Til Wykes. (2015) Cognitive remediation in schizophrenia—now it is really getting personal. Current Opinion in Behavioral Sciences 4, pages 147-151.
Crossref
Crossref